Enanta Pharmaceuticals, Inc. (ENTA) NASDAQ

16.60

+0.89(+5.67%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap255.39M
Enterprise Value424.15M
P/E Ratio-4.33
PEG Ratio-0.38
Price/Sales Ratio5.42
Price/Book Ratio5.48
Enterprise/Revenue8
Enterprise/EBITDA-7.21

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.25
Operating Margin-1.31

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.94

Income Statement

Revenue65.32M
Revenue/Share3.06
Gross Profit65.32M
EBITDA-70.78M
Net Income-81.89M
Diluted EPS-3.84

Balance Sheet

Total Cash188.86M
Total Cash/Share8.83
Total Debt201.06M
Total Debt/Equity3.11
Current Ratio4.21
Book Value Per Share3.03

Price History

52-Week Change172.13
52-Week High17.05
52-Week Low4.09
Moving Average 50 Days12.65
Moving Average 200 Days8.55

Statistics

Average Volume787,280
Shares Outstanding21.33M
% Held by Institutions89.07

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A